MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia

被引:196
作者
Jimenez, C. [1 ]
Sebastian, E. [1 ]
Chillon, M. C. [1 ,2 ]
Giraldo, P. [3 ]
Hernandez, J. Mariano [4 ]
Escalante, F. [5 ]
Gonzalez-Lopez, T. J. [6 ]
Aguilera, C. [7 ]
de Coca, A. G. [8 ]
Murillo, I. [3 ]
Alcoceba, M. [1 ]
Balanzategui, A. [1 ]
Sarasquete, M. E. [1 ,2 ]
Corral, R. [1 ]
Marin, L. A. [1 ]
Paiva, B. [1 ,2 ]
Ocio, E. M. [1 ,2 ]
Gutierrez, N. C. [1 ,2 ]
Gonzalez, M. [1 ,2 ]
Miguel, J. F. San [1 ,2 ]
Garcia-Sanz, R. [1 ,2 ]
机构
[1] Univ Hosp, Dept Hematol, Salamanca 37007, Spain
[2] CIC, Inst Biosanitario Salamanca IBSAL, Salamanca, Spain
[3] Hosp Miguel Servet, Dept Hematol, Zaragoza, Spain
[4] Gen Hosp, Dept Hematol, Segovia, Spain
[5] Hosp Virgen Blanca, Dept Hematol, Leon, Spain
[6] Hosp Gen Burgos, Dept Hematol, Burgos, Spain
[7] Hosp Comarcal Bierzo, Dept Hematol, Leon, Spain
[8] Hosp Clin, Dept Hematol, Valladolid, Spain
关键词
MYD88; mutations; Waldenstrom's macroglobulinemia; IgM monoclonal gammapathies; diagnosis; prognosis; immunophenotyping; MULTIPARAMETER FLOW-CYTOMETRY; MINIMAL RESIDUAL DISEASE; B-CELL; MULTIPLE-MYELOMA; INTERNATIONAL WORKSHOP; MONOCLONAL GAMMOPATHY; RECURRENT MUTATIONS; SOMATIC MUTATION; IMMUNOGLOBULIN; FEATURES;
D O I
10.1038/leu.2013.62
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the MYD88 L265P mutation in Waldenstrom's macroglobulinemia (WM) and B-cell lymphoproliferative disorders by specific polymerase chain reaction (PCR) (sensitivity similar to 10(-3)). No mutation was seen in normal donors, while it was present in 101/117 (86%) WM patients, 27/31 (87%) IgM monoclonal gammapathies of uncertain significance (MGUS), 3/14 (21%) splenic marginal zone lymphomas and 9/48 (19%) non-germinal center (GC) diffuse large B-cell lymphomas (DLBCLs). The mutation was absent in all 28 GC-DLBCLs, 13 DLBCLs not subclassified, 35 hairy cell leukemias, 39 chronic lymphocytic leukemias (16 with M-component), 25 IgA or IgG-MGUS, 24 multiple myeloma (3 with an IgM isotype), 6 amyloidosis, 9 lymphoplasmacytic lymphomas and 1 IgM-related neuropathy. Among WM and IgM-MGUS, MYD88 L265P mutation was associated with some differences in clinical and biological characteristics, although usually minor; wild-type MYD88 cases had smaller M-component (1.77 vs 2.72 g/dl, P = 0.022), more lymphocytosis (24 vs 5%, P = 0.006), higher lactate dehydrogenase level (371 vs 265 UI/L, P = 0.002), atypical immunophenotype (CD23 - CD27 ++ FMC7++), less Immunoglobulin Heavy Chain Variable gene (IGHV) somatic hypermutation (57 vs 97%, P = 0.012) and less IGHV3-23 gene selection (9 vs 27%, P = 0.014). These small differences did not lead to different time to first therapy, response to treatment or progression-free or overall survival.
引用
收藏
页码:1722 / 1728
页数:7
相关论文
共 44 条
[1]   MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type [J].
Anne Pham-Ledard ;
Cappellen, David ;
Martinez, Fabian ;
Vergier, Beatrice ;
Beylot-Barry, Marie ;
Merlio, Jean-Philippe .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (08) :2118-2120
[2]  
BILLADEAU D, 1992, BLOOD, V80, P1818
[3]   Molecular pathogenesis of Waldenstrom's macroglobulinemia [J].
Braggio, Esteban ;
Philipsborn, Casey ;
Novak, Anne ;
Hodge, Lucy ;
Ansell, Stephen ;
Fonseca, Rafael .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09) :1281-1290
[4]   The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J].
Campo, Elias ;
Swerdlow, Steven H. ;
Harris, Nancy L. ;
Pileri, Stefano ;
Stein, Harald ;
Jaffe, Elaine S. .
BLOOD, 2011, 117 (19) :5019-5032
[5]   IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas [J].
Gachard, N. ;
Parrens, M. ;
Soubeyran, I. ;
Petit, B. ;
Marfak, A. ;
Rizzo, D. ;
Devesa, M. ;
Delage-Corre, M. ;
Coste, V. ;
Laforet, M. P. ;
de Mascarel, A. ;
Merlio, J. P. ;
Bouabdhalla, K. ;
Milpied, N. ;
Soubeyran, P. ;
Schmitt, A. ;
Bordessoule, D. ;
Cogne, M. ;
Feuillard, J. .
LEUKEMIA, 2013, 27 (01) :183-189
[6]   Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenstrom's Macroglobulinemia [J].
Garcia-Sanz, R. ;
Ocio, E. M. ;
del Carpio, D. ;
Caballero, A. ;
Magalhaes, R. J. P. ;
Alonso, J. ;
Lopez-Anglada, L. ;
Villaescusa, T. ;
Puig, N. ;
Hernandez, J. M. ;
Fernandez-Calvo, J. ;
Aguilar, A. ;
Martin, A. ;
Lopez, R. ;
Paiva, B. ;
Orfao, A. ;
Vidriales, B. ;
San-Miguel, J. F. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01) :168-171
[7]   Waldenstrom macroglobulinaemia:: presenting features and outcome in a series with 217 cases [J].
García-Sanz, R ;
Montoto, S ;
Torrequebrada, A ;
de Coca, AG ;
Petit, J ;
Sureda, A ;
Rodríguez-García, JA ;
Massó, P ;
Pérez-Aliaga, A ;
Monteagudo, MD ;
Navarro, I ;
Moreno, G ;
Toledo, C ;
Alonso, A ;
Besses, C ;
Besalduch, J ;
Jarque, I ;
Salama, P ;
Rivas, JAH ;
Navarro, B ;
Bladé, J ;
Miguel, JFS .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) :575-582
[8]   Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas [J].
Gonzalez-Aguilar, Alberto ;
Idbaih, Ahmed ;
Boisselier, Blandine ;
Habbita, Naima ;
Rossetto, Marta ;
Laurenge, Alice ;
Bruno, Aurelie ;
Jouvet, Anne ;
Polivka, Marc ;
Adam, Clovis ;
Figarella-Branger, Dominique ;
Miquel, Catherine ;
Vital, Anne ;
Ghesquieres, Herve ;
Gressin, Remy ;
Delwail, Vincent ;
Taillandier, Luc ;
Chinot, Olivier ;
Soubeyran, Pierre ;
Gyan, Emmanuel ;
Choquet, Sylvain ;
Houillier, Caroline ;
Soussain, Carole ;
Tanguy, Marie-Laure ;
Marie, Yannick ;
Mokhtari, Karima ;
Hoang-Xuan, Khe .
CLINICAL CANCER RESEARCH, 2012, 18 (19) :5203-5211
[9]  
Groves FD, 1998, CANCER-AM CANCER SOC, V82, P1078
[10]  
HERRINTON LJ, 1993, BLOOD, V82, P3148